The Role of Regulatory T Cells in Cancer Treatment Resistance
Despite tremendous progress in cancer treatment in recent years, treatment resistance is still a major challenge for a great number of patients. One of the main causes is regulatory T lymphocytes (Tregs), which suppress excessive inflammatory responses via the secretion of immunosuppressive cytokine...
Main Authors: | Anna Dąbrowska, Magdalena Grubba, Amar Balihodzic, Olga Szot, Bartosz Kamil Sobocki, Adrian Perdyan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/18/14114 |
Similar Items
-
The Effectiveness of Cancer Immune Checkpoint Inhibitor Retreatment and Rechallenge—A Systematic Review
by: Adrian Perdyan, et al.
Published: (2023-07-01) -
The Roles Played by Long Non-Coding RNAs in Glioma Resistance
by: Yeonsoo Chae, et al.
Published: (2021-06-01) -
Current Landscape of Therapeutic Resistance in Lung Cancer and Promising Strategies to Overcome Resistance
by: Adnin Ashrafi, et al.
Published: (2022-09-01) -
Management of Pheochromocytomas and Paragangliomas: A Case-Based Review of Clinical Aspects and Perspectives
by: Bartosz Kamil Sobocki, et al.
Published: (2022-05-01) -
Autophagy and its role in osteosarcoma
by: Biao Ning, et al.
Published: (2023-03-01)